Barclays raised the firm’s price target on Ovintiv (OVV) to $57 from $53 and keeps an Overweight rating on the shares. The firm estimates the company is exiting Uinta at 5.5-times 2025 EBITDX and buying in the Montney at 4.5-times with modestly positive impact on the balance sheet. The swap improves Ovintiv’s long-term free cash flow, high-grades Montney inventory, and extends development runway, so “an all-around win-win,” the analyst tells investors in a research note.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OVV:
- FourPoint signs purchase agreement to acquire Ovintiv’s Uinta Basin for $2B
- Ovintiv’s Strategic Acquisition and Divestiture Moves
- Ovintiv to acquire certain Montney assets from Paramount for $2.38B
- Ovintiv price target raised to $46 from $42 at Wells Fargo
- Ovintiv Inc. Reports Q3 2024 Earnings Highlights